Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DHEA treatment: myth or reality?

Bruno Allolio1, Wiebke Arlt

  • 1Dept Medicine, Endocrine and Diabetes Unit, University of Würzburg, Josef-Schneider-Str. 2, 97080 Würzburg, Germany. b.allolio@medizin.uni-wuerzburg.de

Trends in Endocrinology and Metabolism: TEM
|August 7, 2002
PubMed
Summary

Dehydroepiandrosterone (DHEA) supplementation may benefit specific patient groups, but not typically those with age-related decline. Research should focus on adrenal insufficiency and androgen deficiency.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Steroid hormone profiling reveals altered adrenal androgen production in endometriosis.

European journal of endocrinology·2026
Same author

Corrigendum to "Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and Plenadren"[eClinical Medicine 91(2026); 103714].

EClinicalMedicine·2026
Same author

Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretion.

EBioMedicine·2026
Same author

Effects of modified release hydrocortisone on restoration of early morning cortisol, quality of life, and fatigue in adrenal insufficiency (The CHAMPAIN study): a randomised, double-blind, double-dummy, cross-over study comparing Chronocort and Plenadren.

EClinicalMedicine·2026
Same author

Quantification and impact of circulating cardiotonic steroids in the RATE-AF randomised trial of patients with atrial fibrillation and heart failure.

BMC medicine·2025
Same author

Glutamine antagonism suppresses tumor growth in adrenocortical carcinoma through inhibition of de novo nucleotide biosynthesis.

bioRxiv : the preprint server for biology·2025

Area of Science:

  • Endocrinology
  • Neuroendocrinology
  • Aging Research

Background:

  • Dehydroepiandrosterone (DHEA) and its sulfate ester are key adrenal hormones.
  • Serum DHEA levels decrease with age, leading to anti-aging claims for supplementation.
  • Rodent DHEA physiology differs significantly from humans.

Purpose of the Study:

  • To evaluate the efficacy of DHEA supplementation in humans.
  • To differentiate benefits in various conditions versus normal aging.
  • To identify optimal therapeutic targets for DHEA administration.

Main Methods:

  • Review of existing literature on DHEA physiology and supplementation effects.
  • Analysis of DHEA's role as a precursor to sex steroids (androgens, estrogens).

Related Experiment Videos

  • Examination of DHEA's neurosteroid actions on neurotransmitter receptors.
  • Main Results:

    • DHEA significantly impacts mood, well-being, and sexuality in adrenal insufficiency and mood disorder patients.
    • Individuals with physiological, age-related DHEA decline show minimal benefit from supplementation.
    • DHEA acts indirectly via conversion to androgens and estrogens, and directly as a neurosteroid.

    Conclusions:

    • DHEA supplementation is not generally effective for age-related decline.
    • Future research should target DHEA treatment for adrenal insufficiency.
    • Consider DHEA for patients on glucocorticoids and women with androgen deficiency.